Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Bioscience Clinic Introduces Revolutionary Technology to the UAE: Adipose Derived Stem Cell Treatment


News provided by

Bioscience Clinic

20 Apr, 2016, 10:24 GMT

Share this article

Share toX

Share this article

Share toX

DUBAI, UAE, April 20, 2016 /PRNewswire/ --

  • Scientifically Proven Adipose Derived Stem Cell Technology  
  • Unprecedented Results in Anti-Ageing & Body Shaping  
  • Preventative Medicine Possibilities Are Limitless 
  • Provides Undisputed Anti-Ageing Results Published in the Lancet  

Bioscience Clinic Dubai recently introduced its revolutionary Adipose Derived Stem Cell Technology (ADC) to the Middle East. Located in Dubai Health Care City, Bioscience Clinic Middle East is the first regional laboratory and clinic from the European based Bioscience Group, to culture and administrate autologous (the patient's own) cell therapies. This state-of-the-art clinic and lab offers the most exclusive and advanced tailor-made autologous cell therapies for safe, natural and long lasting results.

Now Bioscience Clinic is launching the world's most expensive face cream, using adipose derived stem cells, in Dubai. First there was the 24 karat gold facial, then there was the caviar facial. Next came the high-tech cryo 'freezing' facials, and the 'vampire' facials using a patient's own blood to inject back into their face. There are the face creams that cost $380 (AED 1,395) an ounce that seem to fly off the shelves in Dubai and beauty counters around the world, which claim to be made from rare plants, seaweed extract and use space technology to deliver anti-ageing ingredients to the skin. Bioscience Clinic's ONLYOURS takes this a step further and uses adipose derived stem cell technology to create a skincare suite individually tailored to each patient.

Giuseppe Mucci, founder and owner of Bioscience Clinic, said: "I am delighted to bring this ground-breaking technology to Dubai, which is fast becoming one of the world's leading medical hubs. The forward-thinking attitude of Dubai and the fact that it likes to be the first to do anything is the reason we chose to open our very first clinic outside of our European headquarters in Dubai."

The aesthetic treatments being offered include anti-ageing skincare creams, made using the patient's very own adipose derived stem cells (ADC); facial fillers and skin rejuvenation using the patient's own adipose derived stem cells; natural body shaping, such as breast and buttock augmentation, also using the patient's very own adipose derived stem cells, and more.  

Mr Mucci explains that: "By using the patient's autologous cells, we eliminate the chance of rejection by the body and we eliminate the risk. At the same time, we are maximising the benefits such as encouraging healing and regeneration of the targeted tissues because we are using the adipose stem cells expansion technology. This is completely different from a fat transfer which some clinics offer, as the healing and regeneration benefits do not exist in a straightforward fat transfer. Also, when using a fat transfer to the breasts or face this is usually reabsorbed by the body and disappears within months. With adipose derived stem cells, the results have been proven to be long-lasting."

In typical Dubai fashion, where everything is bigger, better, bolder and, in this case the most expensive, Bioscience Clinic has introduced the world's most expensive skincare 'suite' of three creams. The creams contain hyaluronic acid, collagen and a healthy dose of a patient's very own stem cells. This is the ingredient to which Bioscience attributes its cream's effectiveness, where other creams on the market claim to contain plant stem cells.  

To create the initial skincare suite called ONLYOURS, a small day procedure in a doctor's clinic is performed to extract the patient's adipose (fat) derived stem cells. The stem cells are then used to create the individualised skincare suite ONLYOURS.

For even more dramatic results, patients can opt for a facial using the adipose stem cells they extract, either in the form of stem cell injections to give skin a boost, encourage collagen production, fade lines and pigmentation, improve tone and generally give a more youthful appearance.

Alternatively, the adipose stem cells can be used like a 'filler' to plump the lips or specific areas of the face. The benefit of using your own cells as a filler is that the results are proven and long-lasting, unlike temporary fillers or fat transfers. Both treatments encourage healing and regeneration of the facial tissues.  

The development of the laboratories in Dubai is a result of eight years' experience of existing Bioscience Institute laboratories in Europe, which are considered one of the most advanced and unique in the world when it comes to autologous stem cell application. Bioscience Clinic Dubai extracts a patient's suitable adipose tissue, and then creates the adipose derived stem cells called 'Liposkill' which functions as 'cell bank' for patients to use for a variety of purposes.

Liposkill contains 100% autologous expanded cells collected from a small amount of patients' own fat which is very quick and easy. In fact, patients undergoing liposuction at any plastic surgery clinic in the UAE can request their surgeon to send the fat tissue being extracted to Bioscience Clinic to be turned into Liposkill cells which they can then later use for a variety of purposes ranging from aesthetic to preventative medicine.

Mr Mucci explained that the technology they use is very specific. He said: "Stem cell technology is a buzz word on lots of people's lips, but what they don't realise is that it's not a futuristic dream, it's actually a reality right now. It is important to know that Bioscience Clinic is the only clinic in the world authorised to utilise this technology, and that our adipose derived stem cells technology is scientifically proven and backed by years of research and approval from world medical authorities."

The world's most expensive skincare suite and most expensive facial have launched in Dubai as a result of eight years' experience of existing Bioscience Institute laboratories in Europe, which are considered one of the most advanced and unique in the world, and have now opened their UAE branch in Dubai Healthcare City.

An added benefit is that once the stem cells are extracted from a patient, they can be 'banked' and frozen for use later on, for a variety of purposes ranging from aesthetic to preventative medicine.

About Bioscience Clinic 

Bioscience Clinic in Dubai Healthcare City launched in 2013 and is licensed by the UAE Ministry of Health and Dubai Healthcare City. The clinic offers a range of treatments in the clinic as well as working with a number of other clinics and hospitals throughout the UAE. Bioscience Clinic in Dubai comprises a cell factory and clinic, in which to culture, cryopreserve and administrate autologous cells for therapy. Bioscience facilities are equipped with live cameras, to watch activity in laboratories and maintain strict quality control.

Tel. +971-(0)4-375-7220 - Info@bioinst.ae - http://www.bioinst.ae

For Press Enquiries & Interviews:

terry@lotus-communications.com  
+971-050-421-7189
sara@lotus-communications.com  
+971-056-778-5652

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.